Myriad Genetics | MYGN - EPS Earnings Per Share


Myriad Genetics reported $-0.25 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 -0.11 0.07 Nov/04
FY2026Q2 Jun/2026 -0.25 -0.06 0.05 Jul/30
FY2025Q1 Mar/2026 -0.09 -0.07 -0.03 May/05




Eps Change Date
Agilent USD 1.52 0.08 Jun/2026
Becton, Dickinson and Co. USD 2.52 0.71 Sep/2026
Bio-Rad Laboratories USD 2.65 0.03 Sep/2026
Bruker USD 0.56 0.07 Sep/2026
Danaher USD 1.75 0.19 Sep/2026
Illumina USD 1.44 0.13 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Mettler Toledo International USD 12.57 1.11 Sep/2026
Myriad Genetics USD -0.25 0.16 Jun/2026
OraSure Technologies USD -0.18 0 Dec/2025
Pacific Biosciences Of California USD -0.17 0.12 Dec/2025
Quest Diagnostics USD 2.79 0.33 Sep/2026
Quidel USD 0.31 1.58 Sep/2026
Repligen USD 0.53 0.01 Sep/2026
Revvity USD 1.37 0.04 Sep/2026
Standard Biotools USD -0.07 0.4 Jun/2026
Thermo Fisher Scientific USD 5.18 0.86 Sep/2026
Veracyte USD 0.51 0.03 Sep/2026
Waters USD 4.1 1.05 Sep/2026